These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6024817)

  • 21. Interaction of diuretics and non-steroidal anti-inflammatory drugs in man.
    Favre L; Glasson P; Riondel A; Vallotton MB
    Clin Sci (Lond); 1983 Apr; 64(4):407-15. PubMed ID: 6337769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of saluretics and spironolactone on aldosterone production and electrolyte excretion in man.
    Erbler HC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 286(2):145-56. PubMed ID: 4281879
    [No Abstract]   [Full Text] [Related]  

  • 23. Azolimine: a nonsteroidal antagonist of the effects of mineralocorticoids on renal electrolyte excretion.
    Gussin RZ; Ronsberg MA; Stokey EH; Cummings JR
    J Pharmacol Exp Ther; 1975 Oct; 195(1):8-15. PubMed ID: 1181406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of cortisone and spirolactone on potassium excreting action of aldosterone and desoxycorticosterone.
    UETE T; VENNING EH
    Proc Soc Exp Biol Med; 1962 Apr; 109():760-3. PubMed ID: 13923548
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of furosemide-induced kaliuresis in the rat by trilostane, an inhibitor of adrenal steroidogenesis.
    Harding HR; Creange JE; Potts GO; Schane HP
    Proc Soc Exp Biol Med; 1984 Dec; 177(3):388-91. PubMed ID: 6595676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of aldosterone and spirolactone on urinary sodium and potassium excretion in newborns and infants (author's transl)].
    Solc J; Knorr D
    Z Kinderheilkd; 1974 Jan; 116(2):143-52. PubMed ID: 4816159
    [No Abstract]   [Full Text] [Related]  

  • 27. The "mineralocorticoid-like" actions conferred on corticosterone by carbenoxolone are inhibited by the mineralocorticoid receptor (type I) antagonist RU28318.
    Souness GW; Morris DJ
    Endocrinology; 1991 Nov; 129(5):2451-6. PubMed ID: 1657575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arterial levels and mineralocorticoid activity of 18-hydroxy-11-deoxycorticosterone in the rat.
    Nicholls MG; Brown WC; Hay GD; Mason PA; Fraser R
    J Steroid Biochem; 1979 Jan; 10(1):67-70. PubMed ID: 513718
    [No Abstract]   [Full Text] [Related]  

  • 29. Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations.
    Reyes AJ; Leary WP
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():29-44. PubMed ID: 8435375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MINERALOCORTICOID-BLOCKING PROPERTIES OF A PROGESTERONE-LIKE DERIVATIVE (SC-11835).
    KAGAWA CM
    Endocrinology; 1964 May; 74():724-30. PubMed ID: 14168560
    [No Abstract]   [Full Text] [Related]  

  • 31. Spironolactone: reversal of Na retention in the bilateral adrenal enucleated rat.
    Jacobs RS; Jiu J; Hofmann LM
    Arch Int Pharmacodyn Ther; 1969 Jan; 177(1):245-51. PubMed ID: 5353881
    [No Abstract]   [Full Text] [Related]  

  • 32. [EXPERIMENTAL STUDY OF THE DIURETIC EFFECT OF TRIAMTERENE].
    PENATI MR; SALA G
    Gazz Med Ital; 1963 Jul; 122():217-25. PubMed ID: 14046323
    [No Abstract]   [Full Text] [Related]  

  • 33. Diuretic and vasodilating actions of torasemide.
    Uchida T; Yamanaga K; Kido H; Ohtaki Y; Watanabe M
    Cardiology; 1994; 84 Suppl 2():14-7. PubMed ID: 7954537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The proper use of newer diuretics.
    Laragh JH
    Ann Intern Med; 1967 Sep; 67(3):607-13. PubMed ID: 6042650
    [No Abstract]   [Full Text] [Related]  

  • 35. Requirement of the adrenal for certain urine electrolyte effects of salmon calcitonin in rats.
    Aldred JP; Kleszynski RR; Stubbs RK; Bastian JW; Schlueter RJ
    Proc Soc Exp Biol Med; 1971 Sep; 137(4):1145-51. PubMed ID: 5138436
    [No Abstract]   [Full Text] [Related]  

  • 36. Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention.
    Hensen J; Abraham WT; Dürr JA; Schrier RW
    Am J Nephrol; 1991; 11(6):441-6. PubMed ID: 1840232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reevaluation of DOCA escape phenomenon.
    Möhring J; Möhring B
    Am J Physiol; 1972 Nov; 223(5):1237-45. PubMed ID: 4654355
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of 6-dehydro-DOCA and 6-dehydro-9 alpha-fluorocortisol acetate on the excretion of sodium and potassium in the rat.
    Genard P; Palem-Vliers M
    J Steroid Biochem; 1985 Nov; 23(5A):673-5. PubMed ID: 4079383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of RNA and protein synthesis in the action of aldosterone in the rat.
    Fimognari GM; Fanestil DD; Edelman IS
    Am J Physiol; 1967 Oct; 213(4):954-62. PubMed ID: 6051194
    [No Abstract]   [Full Text] [Related]  

  • 40. The physiological response to aldosterone in adrenalectomized and intact rats and its sex dependence.
    Morris DJ; Berek JS; Davis RP
    Endocrinology; 1973 Apr; 92(4):989-93. PubMed ID: 4686328
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.